|
|
|
Volumn 39, Issue 4, 2002, Pages 1033-1164
|
|
Unbuckling the "chemical straitjacket": the legal significance of recent advances in the pharmacological treatment of psychosis.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLOZAPINE;
NEUROLEPTIC AGENT;
AMERICANS WITH DISABILITIES ACT 1990;
ARTICLE;
BEHAVIOR CONTROL;
CIVIL RIGHTS;
ECONOMICS;
HEALTH INSURANCE;
HISTORY;
HUMAN;
LEGAL APPROACH;
LEGAL ASPECT;
LEGAL LIABILITY;
MALPRACTICE;
MENTAL HEALTH THERAPIES;
METHODOLOGY;
ORGANIZATION AND MANAGEMENT;
POLICY;
PROFESSIONAL PATIENT RELATIONSHIP;
SCHIZOPHRENIA;
TREATMENT REFUSAL;
UNITED STATES;
AMERICANS WITH DISABILITIES ACT 1990;
LEGAL APPROACH;
MENTAL HEALTH THERAPIES;
PROFESSIONAL PATIENT RELATIONSHIP;
ANTIPSYCHOTIC AGENTS;
BEHAVIOR CONTROL;
CIVIL RIGHTS;
CLOZAPINE;
HISTORY, 20TH CENTURY;
HUMANS;
LIABILITY, LEGAL;
MALPRACTICE;
MANAGED CARE PROGRAMS;
ORGANIZATIONAL POLICY;
SCHIZOPHRENIA;
TREATMENT REFUSAL;
UNITED STATES;
|
|
EID: 4444277411
PISSN: 00364037
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (12)
|
|
References (0)
|
